Insmed Reports First Quarter 2021 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Insmed (INSM) Misses Q1 EPS by 1c, Revenues Miss
May 6, 2021 8:19 AM EDTInsmed (NASDAQ: INSM) reported Q1 EPS of ($0.89), $0.01 worse than the analyst estimate of ($0.88). Revenue for the quarter came in at $40.21 million versus the consensus estimate of $41.64 million.
"Insmed is off to a strong start in 2021, with important advancements across each of our three... More
